Schedule 13G
IRMD Schedule 13G filing by BlackRock
BlackRock reported beneficial ownership of 641.1K shares, representing 12% of IRADIMED CORP in this filing.
FiledJul 28, 2026
Ownership dateJun 30, 2026
Reported shares641.1K
Reported ownership12%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
622.9K
Shared voting power
641.1K
Sole dispositive power
641.1K
Shared dispositive power
641.1K
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$94.83as of Jul 28, 2026
Latest tracked price$91.69as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- BlackRock
- CIK
- CIK0002012383
- Accession
- 0002012383-26-002533
- Form
- Schedule 13G
Read the filing in context